Viewing StudyNCT05036135



Ignite Creation Date: 2024-05-06 @ 4:35 PM
Last Modification Date: 2024-10-26 @ 2:13 PM
Study NCT ID: NCT05036135
Status: TERMINATED
Last Update Posted: 2024-06-21
First Post: 2021-08-16

Brief Title: A Study of AV-101 Dry Powder Inhaled Imatinib in Patients With Pulmonary Arterial Hypertension PAH
Sponsor: Aerovate Therapeutics
Organization: Aerovate Therapeutics

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-12-02
Start Date Type: ACTUAL
Primary Completion Date: 2024-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-01
Completion Date Type: ESTIMATED
First Submit Date: 2021-08-16
First Submit QC Date: August 30 2021
Study First Post Date: 2021-09-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-22
Last Update Post Date: 2024-06-21
Last Update Post Date Type: ACTUAL